Torcetrapib
Also known as: Torcetrapib, CP-529414, CP 529414, CS-156, Torcetropib, Ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate, 1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)-
Torcetrapib (CAS 262352-17-0) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C26H25F9N2O4 and a molecular weight of 600.47 g/mol. Key properties include a melting point of 54-58ºC, a boiling point of 504.8±50.0 °C at 760 mmHg, a density of 1.4±0.1 g/cm3 and a flash point of 259.1±30.1 °C. It is classified under GHS with signal word Warning and hazard statements H302 — Harmful if swallowed. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 262352-17-0
- Jingsj CID
- J-1969492-9
- Molecular Formula
- C26H25F9N2O4
- Molecular Weight
- 600.47 g/mol
- Category
- Organic Compounds
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quotePhysicochemical Properties
| Melting Point | 54-58ºC |
|---|---|
| Boiling Point | 504.8±50.0 °C at 760 mmHg |
| Density | 1.4±0.1 g/cm3 |
| Flash Point | 259.1±30.1 °C |
| PSA | 59.08000 |
| LogP | 7.76 |
| Vapor Pressure | 0.0±1.3 mmHg at 25°C |
| Refractive Index | 1.512 |
| Storage Conditions | Store at RT |
GHS Safety & Compliance
- H302 — Harmful if swallowed
Activity & Biological Data
| Additional Information | [1]. Clark RW, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):490-7. [2]. Hu X, et al. Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology. 2009 May;150(5):2211-9. [3]. Barter PJ, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007 Nov 22;357(21):2109-22. [4]. Morehouse LA, et al. Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits. J Lipid Res. 2007 Jun;48(6):1263-72. |
|---|
Frequently Asked Questions
What is the CAS number of Torcetrapib?
The CAS number of Torcetrapib is 262352-17-0.
What are the molecular formula and molecular weight of Torcetrapib?
Torcetrapib has molecular formula C26H25F9N2O4 and molecular weight 600.47 g/mol.
Is Torcetrapib hazardous?
Torcetrapib has GHS signal word Warning and hazard statements H302 — Harmful if swallowed.
What are the upstream and downstream products of Torcetrapib?
For Torcetrapib, Upstream Products: 3,5-Bis(trifluoromethyl)benzyl bromide, 4-(Trifluoromethyl)aniline, (R)-3-Aminopentanenitrile.
Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "Torcetrapib (CAS 262352-17-0)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1969492-9 (accessed 2026-11-09).
Data for reference only; verify product details with suppliers before purchase.